Rush Health adopts new HIE system to improve patient care

Chicago-based Rush Health has made strides to update how it shares electronic health records (EHR) in an effort to better serve its patients.

Rush announced in a statement this week its adoption of the InterSystems HealthShare interoperability platform for collaborative care coordination. The new software will help Rush implement a private health information exchange (HIE), which will allow physicians across the health system view patients’ full medical records. The move will connect primary, specialty, sub-acute and hospital-based providers.

Rush Health has four hospitals, more than 1,100 physician members and 350 non-physician network clinicians, according to the statement. InterSystems, based in Cambridge, Massachusetts, creates software platforms for the healthcare, finance and government sectors.

“We are honored that Rush Health has selected HealthShare to provide the foundational technology on which its connected care initiatives depend,” said Joe DeSantis, vice president for HealthShare at InterSystems, in a statement.

Rush chose InterSystem’s platform over others on the market because they believe InterSystem offers the best solution as a centralized health information hub. It will give Rush providers access to patients’ medication, tests and procedures, which will allow for better and more efficient care.

“Implementation of our HIE is critical to Rush Health’s transition to value-based care,” said Rush CEO Brent Estes in a statement. “It will serve as the hub for all care coordination activities, triggered by real-time monitoring of quality, resource use and cost. It will fill in any gaps in our members’ EHRs.”

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.